Navigation Links
Linagliptin Receives Approval in Europe for the Treatment of Type 2 Diabetes
Date:8/25/2011

RIDGEFIELD, Conn., and INDIANAPOLIS, Aug. 25, 2011 /PRNewswire/ -- Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today received Marketing Authorization from the European Commission for linagliptin 5 mg film-coated tablets (to be marketed under the trade name Trajenta® in Europe) for the treatment of adults with type 2 diabetes. The European Commission has approved linagliptin in combination with metformin and metformin plus sulfonylurea.(1) Linagliptin is also approved for use as monotherapy in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to intolerance, or contraindicated due to renal impairment.(1)

In the U.S., linagliptin 5 mg is marketed under the trade name Tradjenta™ (linagliptin) tablets and was approved by the U.S. Food and Drug Administration (FDA) in May 2011 to be used along with diet and exercise to lower blood sugar in adults with type 2 diabetes.  Linagliptin should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis (increased ketones in the blood or urine). It has not been studied in combination with insulin. Linagliptin is also approved for use in other countries, including Japan (trade name Trazenta).

"The Phase III clinical trial program has demonstrated efficacy with linagliptin in the treatment of adults with type 2 diabetes," said Prof. Klaus Dugi, corporate senior vice president medicine, Boehringer Ingelheim. "We are delighted that linagliptin will soon be available to patients across Europe."

Studies show linagliptin has a demonstrated efficacy and safety profile, reducing hemoglobin A1C (HbA1C or A1C) levels by a mean of -0.6 to -0.7 percent(2,3)  (compared to placebo). A1C is measured in people with diabetes to provide an index of blood glucose control for the previous two to three mo
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes
2. FDA Approves Tradjenta™ (linagliptin) Tablets for the Treatment of Type 2 Diabetes
3. Linagliptin recommended for approval in the treatment of type 2 diabetes in Europe
4. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
5. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
6. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
7. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
8. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
9. CryoCor Receives FDA Approval for Right Atrial Flutter
10. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
11. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Takeda Pharmaceutical Company Limited ("Takeda") today announced ... of data from a 10-year epidemiology study to ... (U.S.) Food and Drug Administration (FDA), ... Ministry of Health, Labour, and Welfare (MHLW) / ... for pioglitazone containing medicines, including ACTOS (pioglitazone HCl). ...
(Date:8/28/2014)... -- Decision Resources Group finds that the market for colorectal cancer ... 2023 in the United States , ... Italy , Spain , the ... . The biosimilar erosion of Roche/Genentech/Chugai,s Avastin and Bristol-Myers ... launch of Eli Lilly,s Cyramza, Taiho Pharmaceutical,s Lonsurf, Alchemia,s HA-irinotecan ...
(Date:8/28/2014)... , Aug. 28, 2014  A candidate Ebola vaccine could be ... and Mali as early as ... vaccines aimed at preventing the disease that has killed more than ... . Human trials of this candidate vaccine, being ... are to be accelerated with funding from an international consortium in ...
Breaking Medicine Technology:Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 2Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 3Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 4Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 5Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 6The Colorectal Cancer Market Will Remain Steady at $7.7 Billion by 2023, With Biosimilar Erosion Of Key Agents Being Balanced Out By the Launch Of Premium-Priced Therapies 2Ebola vaccine trials fast-tracked by international consortium 2Ebola vaccine trials fast-tracked by international consortium 3Ebola vaccine trials fast-tracked by international consortium 4Ebola vaccine trials fast-tracked by international consortium 5Ebola vaccine trials fast-tracked by international consortium 6Ebola vaccine trials fast-tracked by international consortium 7
... 2010 Spectrum Control, Inc. (Nasdaq: SPEC ), ... systems, announced today that it will release its fourth quarter ... after the close of the market. Following the release, Spectrum ... Time, to discuss the Company,s operating results for the quarter ...
... 29, 2010 Pfizer Animal Health today announced ... SYNB ), a privately held, Kansas ... of immunodiagnostic tests for companion and food production ... Veterinary immunodiagnostics, a methodology using antigen-antibody reaction to ...
Cached Medicine Technology:Pfizer Animal Health to Acquire Synbiotics Corporation, Entering Diagnostics Sector 2Pfizer Animal Health to Acquire Synbiotics Corporation, Entering Diagnostics Sector 3Pfizer Animal Health to Acquire Synbiotics Corporation, Entering Diagnostics Sector 4
(Date:8/28/2014)... 2014 Recently, iFitDress.com, the distinguished wedding ... of chic bridesmaid dresses . Included in the ... addition, all of them are provided at deeply discounted ... insists on offering fast and reliable delivery service. All ... order in a short time. As is commonly noted, ...
(Date:8/28/2014)... Recently, iFitDress.com, the popular online supplier of wedding dresses ... range of fashionable bridesmaid dresses . Along with that, ... are offered with big discounts, from 15 to 65 percent ... 16. , The company’s experienced workers never compromise on ... all its products are trendy and graceful. , “We are ...
(Date:8/28/2014)... FL (PRWEB) August 28, 2014 Millennium Treatment ... in America is extremely large, and Millennium Treatment Group is ... and treatment that they need. , According to the ... more than 21 million Americans could have benefited from treatment ... those people received help. This means that there is a ...
(Date:8/28/2014)... TN (PRWEB) August 28, 2014 American ... insurance industry on the Internet will now have a ... Pros company. In one click this year, some of ... at http://quotespros.com/life-insurance.html . , The promoted plans ... Quotes Pros finder tool represent popular policies. The term, ...
(Date:8/28/2014)... As the federal government plans its exit strategy from ... rethink its role in providing health care to veterans, says ... Medicine . , "To simply go on doing more of ... the Veterans Health Administration,s cost and population structure pose in ... for Health Policy & Clinical Practice, and David Auerbach, from ...
Breaking Medicine News(10 mins):Health News:New Selection of Chic Bridesmaid Dresses Available at iFitDress.com 2Health News:Fashionable Bridesmaid Dresses for Autumn 2014 from iFitDress.com 2Health News:Millennium Treatment Group Works to Close Treatment Gap 2Health News:Best Life Insurance Rates for 2014 Now Promoted at Insurer Website 2Health News:A VA exit strategy 2
... 2008 Barr,Pharmaceuticals, Inc. (NYSE: BRL ) today ... 8:30AM Eastern time on Thursday, May 8 to discuss,earnings ... March 31,2008. The number to call from within the ... replay of the conference call will be,available from 10:30AM ...
... 7, 2008 Edmond Medical Center and,ophthalmologists M. Andrew ... Eye Associates, will once again participate in the Mission,Cataract ... those who cannot afford to pay., Appointments can ... If the patient qualifies for the cataract surgery and ...
... to increased risk of falls in the elderly can ... the Electronic Health Record, new Geisinger research shows. ... a persons neurochemistry and may predispose elderly patients to ... death in the elderly. , Geisinger pharmacists and geriatricians ...
... Foster Career School,now offers allied health certificate programs ... offerings include a variety of,online certificate programs such ... broad overview of the human body is ideal ... medical transcriptionists, and,first aid technicians can learn the ...
... Stiefel Laboratories,Inc., the world,s largest independent pharmaceutical company ... has been,promoted to the newly created position of ... chief scientific officer will reinforce the,already critical role ... between,all R&D departments. It also will further strengthen ...
... may not only play a central role in the ... also in much more common acquired chronic lung diseases ... chronic obstructive pulmonary disease (COPD). This is the conclusion ... direction of Assistant Professor Dr. Marcus Mall from the ...
Cached Medicine News:Health News:Barr Will Host An Earnings Conference Call on May 8, 2008 to Discuss the Results for the First Quarter of Calendar 2008 2Health News:Barr Will Host An Earnings Conference Call on May 8, 2008 to Discuss the Results for the First Quarter of Calendar 2008 3Health News:Edmond Medical Center to Provide Free Cataract Surgeries 2Health News:Penn Foster Career School Offers Certificate Programs 2Health News:Stiefel Laboratories Appoints First Chief Scientific Officer 2Health News:Stiefel Laboratories Appoints First Chief Scientific Officer 3Health News:Asthma and smoker's lung: dry airways play a key role 2Health News:Asthma and smoker's lung: dry airways play a key role 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: